Diploma PLC (LON:DPLM – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 5,192.76 and traded as high as GBX 5,520. Diploma shares last traded at GBX 5,510, with a volume of 191,030 shares trading hands.
Analyst Upgrades and Downgrades
DPLM has been the topic of a number of recent research reports. Peel Hunt restated a “buy” rating and set a GBX 6,150 price objective on shares of Diploma in a research note on Tuesday, November 18th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 6,350 price target on shares of Diploma in a report on Wednesday, November 19th. Royal Bank Of Canada upgraded shares of Diploma to an “outperform” rating and boosted their price objective for the company from GBX 4,500 to GBX 6,000 in a research report on Friday, October 3rd. JPMorgan Chase & Co. restated a “neutral” rating and set a GBX 4,440 target price on shares of Diploma in a research note on Wednesday, August 6th. Finally, Jefferies Financial Group lifted their price target on Diploma from GBX 4,500 to GBX 5,200 and gave the company a “hold” rating in a research note on Thursday, September 11th. Four research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 5,605.71.
Get Our Latest Stock Report on DPLM
Diploma Stock Down 0.5%
Insiders Place Their Bets
In other news, insider Geraldine Huse bought 750 shares of the stock in a transaction on Wednesday, November 19th. The stock was acquired at an average price of GBX 3,997 per share, with a total value of £29,977.50. 1.13% of the stock is owned by corporate insiders.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
- Five stocks we like better than Diploma
- The Role Economic Reports Play in a Successful Investment Strategy
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- Market Cap Calculator: How to Calculate Market Cap
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- How to Choose Top Rated Stocks
- Go on a Shopping Spree With 3 Top Retail ETFs
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
